The Global Epidemic of Obesity: Why Global Approaches Won't Work
Tags: OBESITY -- Treatment; NUTRITION disorders -- Treatment
Related Articles
- Let's Treat Obesity Seriously. BRAY, GEORGE A. // American Family Physician;6/15/2010, Vol. 81 Issue 12, p1406
The author discusses the need for physicians to treat obesity seriously. He mentions that 66 percent of U.S. adults are overweight and 33 percent are obese based on a study. He says that obese patients often have different kinds of health problems aside from excess weight like depression,...
- appetite auppresant (Major drug group). // Royal Society of Medicine: Medicines;2002, p84
The article presents information on appetite auppresants. These drugs are used to treat obesity. The first of the drugs acting on the brain, and a number of such drugs that have been used are related and have actions similar to the stimulant amfetamine. The second type of appetite suppressants...
- Obesity spending rises seven-fold. Tanday, Sanjay // GP: General Practitioner;4/10/2009, p4
The article focuses on the seven-fold increase of obesity spending among the Primary Care Trusts (PCTs) in Great Britain over the past three years. One survey shows that half of all PCTs increased their obesity budget and treated more patients than they had done in the previous two years. They...
- A medicinal plants survey for treatment of obesity. Kumar, D. Sathis; Banji, David; Harani, A. // Journal of Pharmacy Research;Mar2011, Vol. 4 Issue 3, p597
The present day problem right from young people including all the age groups is obesity. It is not just fatness but is the indication of overweight. The plants with several chemical constituents with in themselves act as the source for the treatment of the obesity with their valuable...
- Editorial [Hot Topic:Botanical Treatments for Diabetes and Obesity (Guest Editor: Jianping Ye)]. Jianping Ye // Endocrine, Metabolic & Immune Disorders - Drug Targets;Jun2008, Vol. 8 Issue 2, p77
Type 2 diabetes, obesity, metabolic syndrome, and their cardiovascular complications represent a major public health problem around the world. Strategies for effective prevention and treatment for these devastating diseases are of great interest to the general public, government organization,...
- Obesity research continues to spring leaks. Harper, Mary-Ellen // Clinical & Investigative Medicine;Aug97, Vol. 20 Issue 4, p239
Evaluates the role of the uncoupling protein 1 in obesity. Discovery of the uncoupling protein 2; Importance of brown adipose tissue (BAT) in energy balance and obesity development; Potential of B3-adrenergic agonists on awakening BAT thermogenesis; Reported cloning of a third uncoupling protein.
- Market savvy. Horton, Kathleen // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p158
Focuses on the report `Therapeutic Approaches to the Treatment of Obesity,' which examines the market conditions for weight-reducing pharmaceuticals. Key issues in developing novel anti-obesity agents; Other contents of the report; Contact information.
- Management of obesity: Medical treatment options. Carek, Peter J.; Sherer, Jeffrey T. // American Family Physician;02/01/97, Vol. 55 Issue 2, p551
Discusses the medical treatment options available in the management of obesity in the United States (US). Estimated number of adults that are overweight in the US; Treatments that have been used in the management of obesity with varying degrees of success; Risk factors that obesity is...
- Sibutramine for the treatment of obesity. // American Family Physician;03/15/98, Vol. 57 Issue 6, p1434
Focuses on sibutramine which has been approved for the treatment of obesity by the United States Food and Drug Administration. Information on sibutramine; Details on clinical trials administering the drug to persons who were on a reduced-calorie diet; Common side effect associated with sibutramine.
